FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Medical Device Reporting Info Collection

Federal Register notice: FDA seeks comments on an information collection extension entitled Medical Device Reporting 21 CFR Part 803 (OMB Control Num...

Medical Devices

FDA De Novo for Dry Eye Device

FDA grants Lumenis a de novo authorization for its newest intense pulsed light device for improving signs of dry eye disease.

Human Drugs

Drugs Prices Higher in U.S. than 3 Other Countries: GAO

A Government Accountability Office analysis says prices for 20 major prescription drugs were higher in the U.S. than in three other countries.

Medical Devices

Soliton 510(k) Cleared for Tattoo/Cellulite Device

FDA clears a Soliton special 510(k) for modifications to its Resonic device and its use for tattoo removal and cellulite treatment.

Human Drugs

FDA Should Require Better Cancer Drug Trial Representation: Study

Academic medical center researchers document gaps in demographic representation for older adults and black patients in cancer therapeutic pre- and pos...

Federal Register

Info Collection on User Fee Refund

Federal Register notice: FDA seeks comments on an information collection extension entitled Electronic User Fee Payment Request Forms Form FDA 3913 a...

Medical Devices

Pew: Restore FDA Oversight of Lab-developed Tests

Pew Charitable Trusts calls on HHS to reinstate FDAs authority to require premarket reviews for laboratory-developed tests.

Human Drugs

FDA Addressing TIRF REMS Recertification Concerns

FDA says it is working with manufacturers of transmucosal immediate-release fentanyl products to ease provider and pharmacy recertification in a modif...

Human Drugs

FDA Priority Review for Takeda Cancer Drug NDA

FDA grants priority review to a Takeda NDA for mobocertinib to treat some lung cancers.

Human Drugs

Amgen Agrees to Sotorasib Dosing Trial

Amgen agrees to an FDA-proposed post-marketing requirement to conduct a multi-center randomized clinical trial to compare the safety and efficacy of L...